Last updated on October 2018

Study of Adjuvant ONO-4538 With Resected Gastric Cancer


Brief description of study

The purpose of study is to evaluate the efficacy and safety of postoperative adjuvant chemotherapy with Nivolumab in combination with tegafur-gimeracil-oteracil potassium (S-1 therapy) or capecitabine + oxaliplatin (CapeOX therapy), in comparison with placebo in combination with S-1 therapy or CapeOX therapy, in pStage III gastric cancer (including esophagogastric junction cancer) after D2 or more extensive lymph node dissection.

Clinical Study Identifier: NCT03006705

Contact Investigators or Research Sites near you

Start Over

Ono Pharmaceutical Co. Ltd Corporate ...

Aichi Clinical Site2
Nagoya, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Ehime Clinicla Site
Matsuyama, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Hokkaido Clinical Site
Hakodate, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Hokkaido Clinical Site
Sapporo, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Hyogo Clinical Site
Nishinomiya, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Iwate Clinical Site
Morioka, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Kanagawa Clinical Site
Sagamihara, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Kanagawa Clinical Site
Yokohama, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Okayama Clinical Site
Kurashiki, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Osaka Clinical Site
Takatsuki, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Saitama Clinical Site
Hidaka, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Saitama Clinical Site
Kitaadachi-gun, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Shizuoka Clinical Site
Sunto-gun, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Tochigi Clinical Site
Shimotsuke, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Tokyo Clinical Site
Bunkyo-ku, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Tokyo Clinical Site
Chuo-ku, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Tokyo Clinical Site
Koto-ku, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Tokyo Clinical Site
Shinjuku-ku, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Fukuoka Clinical Site
Fukuoka, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Hiroshima Clinical Site1
Hiroshima, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Hiroshima Clinical Site2
Hiroshima, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Kumamoto Clinical Site
Kumamoto, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Niigata Clinical Site
Niigata, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Shizuoka Clinical Site
Shizuoka, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Toyama Clinical Site
Toyama, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Wakayama Clinical Site
Wakayama, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Yamagata Clinical Site
Yamagata, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Busan Clinical Site1
Busan, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Busan Clinical Site2
Busan, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Daegu Clinical Site1
Daegu, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Daegu Clinical Site2
Daegu, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Daegu Clinical Site3
Daegu, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Gwangju Clinical Site
Gwangju, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Gyeonggi-do Clinical Site1
Gyeonggi-do, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Gyeonggi-do Clinical Site2
Gyeonggi-do, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Gyeonggi-do Clinical Site3
Gyeonggi-do, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Gyeonggi-do Clinical Site4
Gyeonggi-do, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Jeollabuk-do Clinical Site
Jeollabuk-do, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Seoul Clinical Site1
Seoul, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Seoul Clinical Site2
Seoul, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Seoul Clinical Site3
Seoul, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Seoul Clinical Site4
Seoul, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Seoul Clinical Site5
Seoul, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Seoul Clinical Site6
Seoul, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Seoul Clinical Site7
Seoul, Korea, Republic of
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Kaohsiung Clinical Site
Kaohsiung, Taiwan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

New Taipei Clinical Site
New Taipei, Taiwan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Taichung Clinical Site
Taichung, Taiwan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Tainan Clinical Site
Tainan, Taiwan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Taipei Clinical Site1
Taipei, Taiwan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Taipei Clinical Site2
Taipei, Taiwan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Aichi Clinical Site1
Nagoya, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Anhui Province Clinical Site
Anhui Province, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Beijing Clinical Site1
Beijing, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Beijing Clinical Site2
Beijing, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Cuangdong Province Clinical Site
Cuangdong Province, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Jiangsu Province Clinical Site1
Jiangsu Province, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Jiangsu Province Clinical Site3
Jiangsu Province, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Jiangsu Province Clinical Site4
Jiangsu Province, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Jiangsu Province Clinical Site5
Jiangsu Province, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Shanghai Clinical Site1
Shanghai, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Shanghai Clinical Site2
Shanghai, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Tianjin Clinical Site1
Tianjin, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Tianjin Clinical Site2
Tianjin, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Zhengjiang Province Clinical Site
Zhengjiang Province, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Guangdong Province Clinical Site1
Guangdong, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Guangdong Province Clinical Site2
Guangdong, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Henan Province Clinical Site1
Henan, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Henan Province Clinical Site2
Henan, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Jiangxi Province Clinical Site1
Jiangxi, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Jiangxi Province Clinical Site2
Jiangxi, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Jilin Province Clinical Site
Jilin, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Shanxi Province Clinical Site
Shanxi, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Zhejiang Province Clinical Site
Zhejiang, China
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Chiba Clinical Site
Kamogawa, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Ehime Clinical Site
Matsuyama, Japan
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.